Skip to main content

Change location

You are currently on the Canada (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
    • Canada (English)
  • Home
  • we are bracco
    We are Bracco

    Welcome to a World of contrasts

    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
  • Our Portfolio

    Proven offerings for a proven difference

    • X-ray/CT
      • Contrast agents

        • Gastrografin
        • ISOVUE
      • Fluoroscopy
        • E-Z-HD
        • E-Z-PAQUE
        • Liquid POLIBAR PLUS
        • Varibar
      • Medical devices

        • Protoco2l Touch
        • CT Exprès 3D
        • EmpowerCTA+
    • MRI
      • Contrast agents

        • MultiHance
        • ProHance
      • Medical Devices

        • EmpowerMR
    • Ultrasound
      • Contrast agents

        • SonoVue
    • Nuclear medicine
      • Contrast agents

        • Choletec
        • Kinevac
    • Interventional cardiology
      • Contrast agents

        • ISOVUE
      • Medical devices

        • ACIST CVi
        • ACIST HDi
        • ACIST RXi
    • Digital solutions
    • Oncology
    • Cardiology
  • Woman looking into microscope
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
  • knowledge
    Knowledge

    Current activities and future opportunities

    • E-learning
    • Partnerships in education
    • Events
  • Ceriano Laghetto
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
  1. Home
  2. Our Portfolio
  3. X-ray/CT
  4. Contrast agents

  5. Gastrografin

Gastrografin®

 

(diatrizoate meglumine and diatrizoate sodium solution USP)

Gastrografin® (diatrizoate meglumine and diatrizoate sodium solution USP) is a palatable lemon-flavored, water-soluble iodinated radiopaque contrast medium for oral or rectal administration used for radiographic examination of segments of the gastrointestinal tract, particularly in cases in which barium examinations would be potentially risky. Gastrografin is also used for examinations for foreign bodies on the pharynx and esophagus and disorders of the swallowing mechanism.

No literature available.

Please consult product monograph on Health Canada website:

 

https://pdf.hres.ca/dpd_pm/00065640.PDF

 

ProductProduct SKUInternal CodeDescription
Gastrografin
Diatrizoate Meglumine 66% and Diatrizoate Sodium 10%
4453070190324x30 mL bottles
4453270190412x120 mL bottles

 

 

PRODUCTS & SERVICES 

 

If you have any questions regarding any Bracco Imaging products or require Service and Support for our equipment.

 

[email protected] 

PROFESSIONAL SERVICES

 

The Professional Services Group is available to assist health care professionals with requests for scientific or medical information about Bracco Imaging products.

 

[email protected]

CUSTOMER SERVICE/ORDER DESK

 

If you need to place an order:

 

[email protected]/[email protected]

Contact us


Please fill out the form below and we will get back to you.

Different countries may have specific processes in place to handle reports of adverse reactions. To report an adverse reaction related to Bracco products, you can find specific contacts and information selecting the page "Pharmacovigilance" of your country.

I have read and I agree with the Bracco Privacy Policy

* I have read the BraccoHealthCare Professionals Privacy Notice and I consent to the processing of my personal data allowing Bracco Imaging SpA (Data Controller) to conduct its business or scientific operations and contact me with promotional communication through email, SMS, and other digital and offline channels, such as mobile apps and social media.

Indications and Usage:

GASTROGRAFIN® (diatrizoate meglumine and diatrizoate sodium solution) is indicated for radiographic examination of the gastrointestinal tract, particularly in cases in which barium suspensions would be potentially risky as well as examinations for foreign bodies in the pharynx and esophagus and disorders of the swallowing mechanism. 

 

For additional information, please consult product monograph on Health Canada website: 

https://pdf.hres.ca/dpd_pm/00065640.PDF

 

IMPORTANT SAFETY INFORMATION:

Not for parenteral use; do not inject.  For oral or rectal administration only.  It should be kept in mind that serious or anaphylactoid reactions that may occur with intravascular administration of radiopaque contrast agents and are theoretically possible following administration by other routes.  Patients at increased risk include those with a history of a previous reaction to a contrast medium, patients with a known sensitivity to iodine per se, and patients with a known clinical hypersensitivity (bronchial asthma, hay fever and food allergies).

Please login to DocCheck
to view our products

Register here Forgot your password?

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182